Exhibitor List
0-9|A|B|C|D|E|F|G|H|I|J|K|L|M|N|O|P|Q|R|S|T|U|V|W|X|Y|Z|All
Keyword Search

Bora Pharmaceuticals

Introduction of Bora Corp, and its division as well as products

CDC Development India Pvt Ltd.

TIIP is meant to be the pioneer industrial park for the High-End Technology, Electronics, EV, and Bio-tech companies to set up their manufacturing and R&D arms in this most advanced city of India, Bangalore.
State of art and Well equipped and comprehensive infrastructure will give the business investors the home coming atmosphere to settle their units within the park and start their operation in fast track.
TIIP is meant to be the pioneer industrial park for the High-End Technology, Electronics, EV, and Bio-tech companies to set up their manufacturing and R&D arms in this most advanced city of India, Bangalore.

Century Biotech Development Corporation

To enhanceand promote a world class biotech industry cluster in Taipei area,Taipei City Government aggressively promoted "Taipei NanKang Biotech Park" to provide a state of the art industrial space to host the development of new drugs and advanced medical devices. It is meant to bring the discovery of research in neighboring Academia Sinica, Taiwan national institute to preclinical study and extend to clinical study and pilotproduction of new drugs. This park is equipped with incubation center to provide the space to host new startups and well planned infrastructure for well-built biotech companies to accommodate their requirements for laboratory, office and pilot production spaces.
With its outstanding location for transportation, next to Nangkang Station, Taipei NanKang Biotech Park will enrich the portfolio of Taipei hi-tech Industrial clusters and itself becomes one of the landmarks of Taipei East District Gateway Project.
Taipei NanKang Biotech Park is equipped with incubation center to provide the space to new startups and well planned infrastructure for biotech companies to accommodate their requirements for laboratory, office and pilot production spaces.

Development Center for Biotechnolgoy

Development Center for Biotechnology (DCB) is founded in 1984 and has its mission to facilitate the ongoing growth and development of Taiwan's biotech industry. To this end, we strive to act as the industry's partner, coordinating resources among government, academia and private companies. DCB plays a key role in building and upgrading Taiwan's biomedical infrastructure, developing critical technologies and culturing Taiwan's professional workforce, and also contually fosters international partnerships and collaborations with research institutes and global biopharmaceuticals throughout Asia and the world.
In both fields of small molecules and biologics, we may provide plenty of drug development services as well as new drug candidates for out-licensing, which are in the preclinical stage, and platforms which can be adopted in your design of drugs.
Info of said candidates for out-licensing, please refer to:
DCB:https://www.dcb.org.tw/
DCB Technology promotion:https://www.dcb.org.tw/posts/729

www.dcb.org.tw/pages/12
www.dcb.org.tw/technologies
https://www.dcb.org.tw/posts/729
本次以次世代醫療為主軸,其中主題1為細胞治療技術,展出中心自有之T細胞及CAR-T優化製程及iPSC合作開發國際聯盟; 主題2之醫療AI則展出鏈結至臨床場域所發展出用於乳癌神經侵犯之病理判讀醫學影像AI引擎。另亦邀請前開二領域內之價值鏈中的關係廠商協同聯展。
Cooperation projects and needs
1. Process development for T-cell & CAR-T therapy: Looking for licensee or clinical partners.
2. iPSC & MSC: Looking for clinical partners for the development of various applications; academic/commercial R&D members who have demands on iPSC.
3. Medical Image AI: Looking for clinical partners for the development of various applications; licensee, business partners or investors.

Diamond Biofund

Diamond BioFund Inc. is the largest fund dedicated to biotechnology innovation and also the first evergreen fund in Taiwan, managing assets worth over 260 million USD. We invited 4 companies from new drugs development, medical devices, diagnostics, and innovative healthcare services in healthcare areas, including 3D Global Biotech, StemCyte, SINEW PHARMA and CHO PHARMA to join Taiwan Healthcare+ EXPO. In addition, three major members of Microbio Group, Microbio Co., Ltd. with two successful drug approvals by the Taiwan Food and Drug Administration (TFDA), Oneness Biotech Co., Ltd. and FOUNTAIN BIOPHARMA will also participate in this event.

EirGenix, Inc.

EirGenix has core capacity in R&D and manufacturing, producing biologics compliant with PIC/S GMP, and has 7 products undergoing development. EirGenix has two main business units:

1.Contract Development & Manufacturing Operation Unit:
EirGenix produces microbial and mammalian cell based biologics compliant with PIC/S GMP from cell line development to drug substance, and provides process development and quality control (QC) analysis for products.

Cell Line Development & Cell Banking Service:
Contract Development & Manufacturing Service:
Analytical Science & QC analysis Service:
Antibody Drug Conjugate (ADC) service: Partnering with Formosa Laboratories, Ltd.

2.Product Development & Operations Unit:
EirGenix currently has seven biologics undergoing development.

EG12014/EGI014 (Trastuzumab Biosimilar) treats HER2 gene variance cancer. It received approval from US FDA, Taiwan FDA, EMA...etc and began phase III clinical trial.
EG1206A (Pertuzumab Biosimilar) treats HER2 gene variance cancer.
EG13074 (New Formulation) treats HER2 gene variance cancer.
TSY0110(EG12043) (Antibody-Drug Conjugate) treats HER2 gene variance cancer.
EG12021 (Bevacizumab Biosimilar) inhibits cancer by anti-angiogenesis.
EG74032 (CRM197 Carrier Protein) can be used for vaccination.
EG62054 (Biosimilar)
EirGenix has core capacity in R&D and manufacturing, executing Contract Development & Manufacturing Services for clients producing microbial and mammalian cell based biologics compliant with PIC/S GMP regulation.
Cooperation projects and needs
1. Provide Cell Line Development, Manufacturing Process Development , and Analytical Service
2. Provide PIC/S GMP Manufacturing Service of biologics including recombinant protein, fusion protein, plasmid, monoclonal antibody, biosimilar etc.
3. Provide Analytical Science & QC analysis Service

Golden Biotechnology Corp.

Golden Biotechnology Corp.,leading pharma in cancer and other new drugs . Received Orphan Drug Designations by US FDA for Pancreatic Cancer, AML and HCC and Pancreatic Cancer by EU EMA. Completed first stage of Phase II trial of NSCLC and released in 2019 ASCO meeting.Winner of the Advance Queensland - Johnson & Johnson Innovation QuickFire Challenge in Alzheimer's Disease study in 2016. In 2018 , successful unblinding on clinical trial of hyperlipidemia. Welcome visit us at Booth S931 Biotech &Pharmaceuticals Area.
1. Golden Biotechnology Corp.'s latest developments and clinical progress of new drug Antroquinonol® in Non-small Cell Lung Cancer(NSCLC), Pancreatic Cancer, Liver Cancer(HCC), Hyperlipidemia, Atopic Dermatitis, Hepatitis B, Alzheimer's disease, Non alcoholic Steatohepatitis(NASH) and AML.
2. EBH(EvidenceBase Healthy)
Golden Biotechnology Corp.,leading pharma in cancer and other new drugs . Received Orphan Drug Designations by US FDA for Pancreatic Cancer, AML and HCC . Completed first stage of Phase II trial of NSCLC and released in 2019 ASCO Meeting.

HCT Regenerative

Regenerative Medicine, Human Cellular and Tissue based Products, Biologics

Insilico Taiwan

Insilico Medicine is an artificial intelligence company headquartered in Hong Kong, with R&D and management resources in the USA, China, Russia, UK, Taiwan, and Korea sourced through hackathons and competitions. The company and its scientists are dedicated to extending human productive longevity and transforming every step of the drug discovery and drug development process through the end-to-end drug discovery pipeline. It specializes in generative adversarial networks, reinforcement learning, transfer learning, and meta-learning technologies. In 2017, NVIDIA selected Insilico Medicine as one of the Top 5 AI companies for its social impact. In 2018, Insilico was named one of the global top 100 AI companies by CB Insights. In 2018 it received the Frost & Sullivan 2018 North American Artificial Intelligence for Aging Research and Drug Development Award.
Insilico Medicine is an AI company, are dedicated to extending human productive longevity and transforming every step of the drug discovery and development process through excellence in biomarker discovery, drug development, aging research.

Kevin Steel Corp.

Sanitary Ball Valve
High Purity Ball Valve
ASME BPE Ball Valve
Special Alloy Valve
Sampling Valve
Dis
Kevin Steel Corp. is a Bio-Med/BPE focus professional valve manufacturer and solution provider. Through many decades of valve/control valve experience, we manage to provide innovating solutions and products for our worldwide customers.